Immediate Impact

66 standout
Sub-graph 1 of 23

Citing Papers

Customizable virus-like particles deliver CRISPR–Cas9 ribonucleoprotein for effective ocular neovascular and Huntington’s disease gene therapy
2025 Standout
Gene Editing for CEP290 -Associated Retinal Degeneration
2024 Standout
3 intermediate papers

Works of Robert J. Munger being referenced

Preclinical Safety Evaluation of AAV2-sFLT01— A Gene Therapy for Age-related Macular Degeneration
2010

Author Peers

Author Last Decade Papers Cites
Robert J. Munger 123 148 16 77 16 272
Cindy Farman 77 115 9 58 17 314
Réka Albert 57 64 17 110 23 294
Kirsten Bucher 72 202 4 25 15 330
J L Goyal 96 54 4 82 15 237
Chieko Masuda 93 110 95 11 300
Amy M. Knollinger 158 39 36 126 15 282
Erlend Christoffer Sommer Landsend 95 111 107 16 276
Melvin I. Roat 95 52 2 108 16 332
Elson L. Craig 154 138 7 38 13 302
M Sterkers 232 81 25 123 23 305

All Works

Loading papers...

Rankless by CCL
2026